Evidence of Age-Dependent Activity Increase of Poly(C)-Avid Serum Ribonuclease in Man by Francesconi, M. et al.
Francesconi, Meryn, Moser and Bauer: Age-dependent increase of poly(C)-avid serum ribonuclease in man 17
J. Clin. Chem. Clin. Biochem.
Vol. 19,1981, pp. 17-20
Evidence of Age-Dependent Activity Increase of Poly(C)-Avid Serum Ribonuclease in Man
By M. Francesconi, S. Meryn,K. Moser
Erste Medizinische Universitätsklinik (Vorstand Prof. Dr. Dr. h. c. E. Deutsch), Wien and
K. Bauer
Institut für klinische Chemie und Laboratoriumsdiagnostik (Vorstand Pro f. Dr. F. Gabi), Universität Wien
(Received February 19/June 19,1980)
Herrn Professor Dr. Franz Gabi zum 60. Geburtstag gewidmet
Summary: The activity of ribonuclease (EC 3.1.4.22) was estimated in sera of 401 normal subjects (normal renal
function, no signs of catabolism), age ranging from 16 to 100 years (mean: 50.25 ± 19.98) with Poly (C) as substrate.
Further activity was measured with the substrates Poly (U), Poly (A) and Poly (G) in 10 sera from each age decade
between 21—30 years and 81-90 years. Greatest activity was found with Poly (C) as substrate (mean: 15.88 kU/1
± 9.57). Covariant analysis (age as covariant) revealed no sex-related activity distribution at any age, whereas the
age-dependent activity increase was highly significant (p < 0.001; 11-20 years: 9.48 kU/1 ±3.07; 81—90 years:
34.72 kU/1 ± 5.88). Activity with the other substrates was very low and constant throughout all ages. It seems to
be mandatory to consider the age of the patient when interpreting ribonuclease activity.
Nachweis der altersabhängigen Aktivitätszunahme der Poly(C)-aviden Ribonuclease im Serum beim Menschen
Zusammenfassung: Die Aktivität der Ribonuclease (EC 3.1.4.22) wurde im Serum von 401 Normalpersonen (nor-
male Nierenfunktion, kein Katabolismus), Alter 16-100 Jahre (Mittel 50,25 ± 19,98) mit Poly (C) als Substrat ge-
messen. Weiters wurde die Aktivität mit den Substraten Poly (U), Pply (A) und Poly (G) in jeweils 10 Sera der Al-
tersdekaden 21—30 bis 81—90 Jahren gemessen. Die größte Aktivität wurde mit Poly (C) als Substrat gefunden
(Mittel 15,88 kU/1 ± 9,57). Mittels Kovarianzanalyse (Alter als Kovariante) zeigte sich keine geschlechtsgebundene
Aktivitätsverteilung, während eine hochsignifikante altersbedingte Aktivitätszunahme nachgewiesen werden konnte
(p < 0,001; 11-20 Jahre: 9,48 kU/1 ± 3,07; 81-90 Jahre: 34,72 kU/1 ± 5,88). Die Aktivität mit den drei anderen
Substraten war sehr niedrig und konstant über alle Altersgruppen. Es erscheint erforderlich zu sein, das Alter der
Patienten bei der Beurteilung der Ribonucleaseaktivität zu berücksichtigen.
Introduction whether preferential cleavage of homopolyribocytidylates
. „ , . , is common on sera of both sexes and all age groups.Sijice the discovery of ribonuclease activity in human
serum, efforts have been made to characterize this
enzyme (ribonuclease I; ribonucleate 3'-pyrimidino-
oligonucleotide hydrolase; EC 3.1.4.22) with regard to Materials and Methods
activity and clinical relevance in different disease condi-
tions (1,2, 3). There is evidence of elevated ribonuclease Probands and samples
- activity due « faired renal function (245) , during f-/s^
pregnancy (6) and in catholic conditions (7). Some ^ ^
 had ^  ^  m^
authors pointed out that the enzyme may be of vdue as ^ ^ .^  ^  ^
 < ^  ^ ^
a cancer diagnostic (8, 9, 10). In recent publications Creatinine1) < 100 /l; Creatinine-clearance > 100 ml/min
this latter suggestion has been looked at more critically (13).
(11,12). It was the aim of this investigation to elucidate (^
 no sjgns Of catabolic condition: weight loss < 2 kg within
the influence of sex and age on ribonuclease activity, a 4 weeks before blood sampling.
question of great importance in view of the age distribu-
tion of tumor patients. Furthermore it was investigated l ) SMA-60/6 Technicon Corp.
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Ribonuclease assay Tab.
Enzyme was assayed by a modified Zimmerman method (14).
Tan ml f\F fictino vpnmie f»1r»r»H u/ao allmi/prf tn rlnt for 1 hnur
at room temperature and was then centrifuged at 750 g for Age
15 minutes. Ribonuclease estimation was performed either (a)
immediately thereafter, or the serum was stored frozen at - 20 °C
and enzyme was assayed at a later time.
1. Distribution of Poly (C)-avid ribonuclease activity in age
decades from 11-20 to 91-100 years.
Sex n Poly(C)-avid ribonuclease
(kU/1)
÷ ± s Median
Reaction mixture consisted of 100 Mg Poly (C)2), 0.15 ml of 11- 20 d 4 8.36 ± 2.89
buffer containing 0.1 mol/1 KH2PO4 and 0.05 mol/1 Na2B407 9 11 10.61 ± 3.26
10 H2O with pH 6.5; 50 jul of serum diluted 1:200 with saline. _Ë
Zl-f J O /^ ;r.0d ± J.1JL
After an incubation period of 15 minutes at 37 °C samples 9 35 10.46 ± 3.23
were transferred to an ice bath and the reaction was stopped
with 0.25 ml of ice-cold 1.2 mol/1 perchloric acid containing 31~ 40 6 19 11.40 ±3.38
0.02 mol/1 lanthanum nitrate. After 20 minutes of ice bath the 9 47 11·70 ± 3·34
precipitate was removed by centrifugation at 12000 £ for 41«. 50 d 18 12.61 ± 3.55
30 minutes at 4 °C. The supernatant was diluted with ß?2è, 9 3l 13.2l ± 3.63
absorbance was measured at 278 nm (Zeiss, PMQ 3). Enzyme '
and substrate blanks were run side by side. The same procedure 51-60 d 27 14.39 ± 3.79
was employed with the substrates Poly (U)2), Poly (A)2) and 9 41 14·74 * 3·84
Poiy(G)2). ' 61-70 d 17 19.63 ± 4.43
9 49 16.41 ±4.01-
Activity definition
 ?1_ gQ rf ^ 24.43 ± 4.90
One ribinuclease unit is defined as the activity that renders 9 29 24.13 ± 4.91
1 ìéçïÀ of Poly (C) acid soluble in one minute at pH 6.5 and
 Q1 QA Q .Ë QA
37 °C. Analogously activities are defined for the cleavage of ei~ yu f
 t ° ^0.94 ± ^ °
Poly (U), Poly (A) and Poly (G). The absorbance and the 9 15 . 3 '5 ± 6'2U
molar absorption coefficient were estimated with reference to 91-100 d 1 42.18
the monomeres CMP, UMP, AMP and GMP in accordance with 9 4 41 .15 ± 6.41
the Pabsl-lables3). Obviously not all acid soluble material in the
supernatant consists of mononucleotides, but the differences in
absorption coefficients of mono- and oligomeres were negligible
in this case.
Evaluation ' 60
Activities were evaluated separately for the two sexes and
additionally for age, with ages grouped as decades: youngest
decade 11-20 years, oldest decade 91-100 years. By means of 50
covariant analysis (age as covariant) it was investigated whether
there was an age and/or sex-dependent activity distribution (15).
The activities with Poly (U), Poly (A) and Poly (G) as substrates
were compared with the activities obtained using Poly (C) within _ A0
each decade (n = 10). §
.^
Results |30
3
In order to show the uniform distribution of ribonuclease .·!
activity between both sexes within each decade of age, * 20
mean values, standard deviation and the median was
calculated for male and female subjects separately,
results are given in table 1 . Due to the low number of 1°
samples investigated no median could be calculated for
males of 1 1-20 and 91-100 years, or for females of
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In adults between 21 and 90 years covariant analysis QG
revealed no sex-linked differences in enzyme activity,
whereas the age-dependent activity increase was hiehlv Fig* le Correlation between age and ribonuclease activity with
cioniii^ont fE - ifi oc ^ Ë ð Ë À \ ô r- 1 -. Polv <c) as substrate (n = 401; r = 0.683; p < 0.001;
significant (F - 38.25; p < 0.001). In figure 1 nbonu-
 y = 0.329x + 0.638). Drawing from a plotter diagramme.
clease activity of all sera (abscissa) is plotted against the Numerous points represent 2-4 identical results,
age of the subject (ordinate). According to the results of
covariant analysis there was a significant correlation be-
tween age and enzyme activity (r = 0.683; p < 0.001). There is a rapid progression of enzyme activity in subjects
2) Miles Research products, Miles Laboratories, Inc. Elkhart,
Indiana 46514, USA.
3) P. L. Biochemicals Milwaukee, Wisconsin 53205 Eighth
Printing, 1976.
older than 60 years, as can also be noticed from the mean
values in table L
Ten samples for each decade between 21 and 90 years
were also assayed for enzymatic activity with the sub-
strates Poly (U), Poly (A) and Poly (G), and the values
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compared with activity towards Poly (C). As can be seen
in table 2 enzyme activity with Poly (C) as substrate
shows the typical increase depending on the age of the
subject, whereas activity towards all other polyribonu-
cleotides is markedly lower and remains practically un-
changed with increasing age.
Discussion
The great variety of ribonuclease assay techniques and
resulting activity definitions makes it difficult to compare
results of different authors. This is mainly due to the use
of biological substrates, such as RNA preparations from
E. coli (rnRNA as well as tRNA) and yeast RNA (1,6,
4, 8, 16, 17,18). The use of synthetic homopolyribonu-
cleotides led to a methodical standardisation (3,14). By
this it could be demonstrated that preparations of differ-
ent organs with ribonuclease activity exert their activity
preferentially on different synthetical polyribonucleo-
tides. This was shown for liver, spleen, pancreas, prostate
and leucocytes (4,19-22).
Since the investigations of Migliarese (23) elevated
activities of ribonuclease have been repeatedly demon-
strated in cancer patients (8,9, 10,16, 24,25). In the
current publications analyzing the clinical relevance of
ribonuclease and using the above mentioned enzyme
assay technique (10, 11, 26, 27), the influence of age on
enzyme activity was not evaluated in an appropriate
statistical manner and considered when discussing results
in patients. Furthermore normal values are mostly based
on activities of poorly defined normal controls.
Our results prove evidence that:
a) preferential cleavage of Poly (C) in human serum as
described byReddl (20) is common is both sexes and
all age groups;
b) there is a progressive increase of enzyme activity with
Poly (C) as substrate with increasing age.
The reason for this behaviour is not clear, two aspects
should be taken into consideration:
1. decreased ribonuclease clearance in the older subject
2. decreased ribonuclease inhibition in the older subject.
Ribonuclease clearance: activity of serum ribonuclease
depends on renal function, mainly on glomerular filtra-
tion. It is well known that diseases leading to a deteriora-
tion of glomerular filtration consecutively lead to a
marked increase of enzyme activity (2,4, 5). It may be
presumed that in the older subject there is a decrease of
glomerular filtration that is not reflected by the method
of creatinine clearance. In accordance with this hypo-
thesis we found elevated enzyme activites in patients
with diabetes mellitus or angiopathies and "normal"
renal function. Another explanation could be an age-
dependent enzyme-oligomer formation, giving rise to
elevated enzyme activity due to diminished glomerular
filtration.
Ribonuclease inhibition: since the investigations of
Roth (28) there is evidence of a ribonuclease inhibitor
in liver preparations. The inhibitory effect on the enzyme
of polyadenylates and the reversibility by depolyadenyla-
tion (29) and polyamines (30, 31) in vitro are unlikely
to cause activity changes in vivo. Ribonuclease activity
resulting from a balance of activity and inhibition in
vivo will be the topic of further investigations.
Enzymatic cleavage of Poly (U), Poly (A) and Poly (G)
remains throughout all ages at a very low and identical
level. Most probably Poly (C) specific ribonuclease is
not involved in the degradation of other polyribonucleo-
tides. This cleavage could be a consequence of the action
of unspecific phosphodiesterases.
In conclusion it seems mandatory to consider the age of
the patient when elevated ribonuclease activities are
interpreted. Only those increases that exceed levels for
the respective age should be taken to indicate the possi-
bility of pathologic activities.
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Tab. 2. Ribonuclease activity with Poly (C), Poly (U), Poly (A) and Poly (G) as substrates in age decades from 21-30 to 81-90 years.
Age Substrate
Poly (C) Poly (U)
Ribonuclease catalytic activity concentration
Poly (A) Poly (G)
21-30
31-40
41-50
51-6¼
61-70
71-80
81-90
x± s
OcU/1)
11.21 ± 3.40
11.20 ±3.40
12.00 ± 3.50
13.20 ± 3.60
14.00 ± 3.70
27.00 ± 5.20
40.60 ± 6.40
(kU/1)
1.10
1.06
0.99
1.20
1.20
1.12
1.10
Fraction of ÷
substrate (kU/1)
Poly (C)
0.098
0.094
0.083
0.091
0.086
0.041
0.027
0.43
0.36
0.32
0.28
0.49
0.27
0.24
Fraction of ÷
substrate (kU/i)
Poly (C)
0.038
0.032
0.027
0.021
0.035
0.010
0.006
0.62
0.55
0.60
0.60
0.63
0.60
0.61
Fraction of
substrate
Poly (C)
0.055
0.049
0.050
0.045
0.045
0.002
0.015
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